KR20230175241A - 형태 전환 나노구조체 - Google Patents

형태 전환 나노구조체 Download PDF

Info

Publication number
KR20230175241A
KR20230175241A KR1020237039385A KR20237039385A KR20230175241A KR 20230175241 A KR20230175241 A KR 20230175241A KR 1020237039385 A KR1020237039385 A KR 1020237039385A KR 20237039385 A KR20237039385 A KR 20237039385A KR 20230175241 A KR20230175241 A KR 20230175241A
Authority
KR
South Korea
Prior art keywords
nanostructure
coupling
molecule
entity
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237039385A
Other languages
English (en)
Korean (ko)
Inventor
보우터 엥겔렌
크리스티안 지글
헨드릭 디에츠
Original Assignee
테크니쉐 우니베르지테트 뮌헨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 테크니쉐 우니베르지테트 뮌헨 filed Critical 테크니쉐 우니베르지테트 뮌헨
Publication of KR20230175241A publication Critical patent/KR20230175241A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/35—Valency

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1020237039385A 2021-04-22 2022-04-22 형태 전환 나노구조체 Pending KR20230175241A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21169934.3A EP4079330A1 (en) 2021-04-22 2021-04-22 Conformation switching nanostructures
EP21169934.3 2021-04-22
PCT/EP2022/060737 WO2022223802A1 (en) 2021-04-22 2022-04-22 Conformation switching nanostructures

Publications (1)

Publication Number Publication Date
KR20230175241A true KR20230175241A (ko) 2023-12-29

Family

ID=75659780

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237039385A Pending KR20230175241A (ko) 2021-04-22 2022-04-22 형태 전환 나노구조체

Country Status (6)

Country Link
US (1) US20240199763A1 (cg-RX-API-DMAC7.html)
EP (2) EP4079330A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024515346A (cg-RX-API-DMAC7.html)
KR (1) KR20230175241A (cg-RX-API-DMAC7.html)
CN (1) CN117222437A (cg-RX-API-DMAC7.html)
WO (1) WO2022223802A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4399528A1 (en) 2021-09-09 2024-07-17 Nautilus Subsidiary, Inc. Characterization and localization of protein modifications
EP4764494A1 (en) * 2024-12-20 2026-06-24 Plectonic Biotech GmbH Conjugates for analyte detection and quantification

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020254684A1 (en) * 2019-06-21 2020-12-24 Tilibit Nanosystems Gmbh Conditionally switchable nanostructure

Also Published As

Publication number Publication date
US20240199763A1 (en) 2024-06-20
EP4326342A1 (en) 2024-02-28
CN117222437A (zh) 2023-12-12
JP2024515346A (ja) 2024-04-09
WO2022223802A1 (en) 2022-10-27
EP4079330A1 (en) 2022-10-26

Similar Documents

Publication Publication Date Title
Roxo et al. G-quadruplex-forming aptamers—characteristics, applications, and perspectives
Jain et al. Comparison of avidin, neutravidin, and streptavidin as nanocarriers for efficient siRNA delivery
Edwardson et al. Virus-inspired function in engineered protein cages
Burckhardt et al. Virus movements on the plasma membrane support infection and transmission between cells
Li et al. Aptamer displacement reaction from live-cell surfaces and its applications
Smith et al. Nucleic acid nanostructures for biomedical applications
US9297013B2 (en) pRNA multivalent junction domain for use in stable multivalent RNA nanoparticles
Kamiya et al. Pharmacokinetic and pharmacodynamic considerations in gene therapy
Chen et al. Framework nucleic acid nanomaterials for central nervous system therapies: design for barrier penetration, targeted delivery, cellular uptake, and endosomal escape
Backlund et al. Protein and antibody delivery into difficult-to-transfect cells by polymeric peptide mimics
JP2014533953A (ja) 治療用rnaスイッチ組成物及び使用方法
US10155946B2 (en) Particle-nucleic acid conjugates and therapeutic uses related thereto
Kim et al. Molecular Complementarity of Proteomimetic Materials for Target‐Specific Recognition and Recognition‐Mediated Complex Functions
Andrea et al. Adsorption of oligo-DNA on magnesium aluminum-layered double-hydroxide nanoparticle surfaces: Mechanistic implication in gene delivery
Shi et al. Virus mimetic framework DNA as a non-LNP gene carrier for modulated cell endocytosis and apoptosis
Liu et al. Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles
Colombo et al. Complexity in the therapeutic delivery of RNAi medicines: an analytical challenge
US20190117572A1 (en) Microfluidic-formulated leukosome compositions and fabrication methods therefor
US20240199763A1 (en) Conformation switching nanostructures
Menon et al. Designer, Programmable DNA‐peptide hybrid materials with emergent properties to probe and modulate biological systems
Khorenko et al. Foscarnet-type inorganic-organic hybrid nanoparticles for effective antiviral therapy
Wu et al. Precise construction of DNA origami‐based materials for functional regulation on biological interface
Egorova et al. Anti-Angiogenic RNAi-Based Treatment of Endometriosis in a Rat Model Using CXCR4-Targeted Peptide Nanoparticles
Ma et al. AIDS treatment with novel anti-HIV compounds improved by nanotechnology
Levina et al. TiO2∼ DNA nanocomposites as efficient site-specific antiviral agents against influenza A virus in cell culture

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20231115

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250314

Comment text: Request for Examination of Application